ThromboGenics
Recent developments from ThromboGenics highlighted
Published in Healthcare Mergers, Acquisitions and Ventures Week, June 30th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at ThromboGenics.
Report 1: ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular disease, today provided an update highlighting progress with its pre-clinical development portfolio. As part of this update, the Company announced an out-licensing agreement for the antibodies against platelet glycoprotein Ib (anti-GPIb) and von Willebrand Factor (anti-vWF), which it has been developing as novel anti-thrombotic agents. This out-licensing deal has been concluded so that the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- A.P. Pharma
A.P. Pharma Receives $2.5 Million Milestone Payment - A.P. Pharma, Inc.
A.P. Pharma Prices $35 Million Common Stock Offering - AARP
AARP Members Rally on Capital Lawn in Albany for Prescription Drug Marketing Reform - AARP
AARP, Business Roundtable and SEIU Deliver Endorsed Health IT Principles to Congress - AARP
Leading National Organizations and Physicians Call on New York State to Lead Nation in Rx Marketing Reform - Abbott
Abbott Declares 334th Consecutive Quarterly Dividend - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
